All Stories

  1. Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species

    Article • NeuroImage Clinical, August 2018, Elsevier

    Dr Konstantinos Chiotis

  2. Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer’s disease dementia

    Article • Molecular Psychiatry, May 2017, Nature

    Dr Konstantinos Chiotis

  3. Clinical validity of increased cortical uptake of amyloid ligands on PET as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework

    Article • Neurobiology of Aging, April 2017, Elsevier

    Dr Konstantinos Chiotis

  4. Tau PET imaging: present and future directions

    Article • Molecular Neurodegeneration, February 2017, Springer Science + Business Media

    Dr Konstantinos Chiotis

  5. Regional tau deposition measured by [18F]THK5317 positron emission tomography is associated to cognition via glucose metabolism in Alzheimer’s disease

    Article • Alzheimer s Research & Therapy, September 2016, Springer Science + Business Media

    Dr Konstantinos Chiotis

  6. Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study

    Article • Brain, July 2016, Oxford University Press (OUP)

    Dr Konstantinos Chiotis

  7. Imaging in-vivo tau pathology in Alzheimer’s disease with THK5317 PET in a multimodal paradigm

    Article • European Journal of Nuclear Medicine and Molecular Imaging, March 2016, Springer Science + Business Media

    Dr Konstantinos Chiotis

  8. Comparison of Early-Phase 11C-Deuterium-L-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease

    Article • Journal of Nuclear Medicine, February 2016, Society of Nuclear Medicine

    Dr Konstantinos Chiotis

  9. Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer’s disease

    Article • Brain, January 2016, Oxford University Press (OUP)

    Dr Konstantinos Chiotis

  10. Tracer Kinetic Analysis of (S)-18F-THK5117 as a PET Tracer for Assessing Tau Pathology

    Article • Journal of Nuclear Medicine, January 2016, Society of Nuclear Medicine

    Dr Konstantinos Chiotis

  11. Amyloid PET in European and North American cohorts; and exploring age as a limit to clinical use of amyloid imaging

    Article • European Journal of Nuclear Medicine and Molecular Imaging, July 2015, Springer Science + Business Media

    Dr Konstantinos Chiotis

  12. Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease

    Article • Journal of Alzheimer s Disease, April 2015, IOS Press

    Dr Konstantinos Chiotis

  13. Role of Anthropometric Characteristics in Idiopathic Carpal Tunnel Syndrome

    Article • Archives of Physical Medicine and Rehabilitation, April 2013, Elsevier

    Dr Konstantinos Chiotis